The Involvement of Platelets and the Coronary Vasculature in Collagen-Induced Sudden Death in Rabbits

Summary

The mechanism of collagen-induced sudden death in rabbits was studied by measuring blood pressure (BP), heart rate, ECG, the continuous platelet count and the plasma levels of thromboxane B₂ (TxB₂) and 6-keto prostaglandin Fia (6-keto PGF_1α). Death was preceded by myocardial ischaemia and a sharp fall in BP which occurred before any fall in platelet count was observed. The calcium entry blockers (CEBs), verapamil, nifedipine and PY 108-068 protected the rabbits from sudden death without any significant effect on the decrease in the platelet count or increase in plasma TxB₂ levels. 6-keto PGF_1α could not be detected in any plasma samples. Indomethacin and tri-sodium citrate also protected the rabbits but significantly reduced the fall in platelet count and plasma TxB₂. In vitro studies on isolated aortae indicated that verapamil non-specifically inhibited vasoconstriction induced by KC1, adrenaline and U46619 (a thromboxane agonist). It is concluded that CEBs physiologically antagonize the vasoconstricting actions of platelet-derived substances and that it is coronary vasoconstriction that is primarily the cause of death.

Key words

Platelets - Thromboxane - Calcium entry blockers - Sudden death

• References

• 1 Silver MJ, Hoch W, Kocsis JJ, Ingerman CM, Smith JB. Arachidonic acid causes sudden death in rabbits. Science 1974; 183: 1085-1086
• 2 Maseri A, Chierchia S. Coronary vasospasm in ischemic heart disease. Chest 1980; 78: 210-215
• 3 Mallarkey G, Kendle KE, Smith GM. The effect of verapamil on lethal doses of collagen in rabbits. Br J Pharmacol 1982; 76: 177 P
• 4 Smith GM, Freuler E. The measurement of intravascular aggregation by continuous platelet counting. Bibl Anat 1973; 12: 229-234
• 5 Mallarkey G, Smith GM. In vivo platelet aggregation in the rat: dependence on extracellular divalent cation and inhibition by non-steroidal anti-inflammatory drugs. Br J Pharmacol 1984; 81: 31-39
• 6 Mallarkey G, Smith GM. The effect of arachidonic acid metabolism on intravascular platelet aggregation in rats. Thrombos Res 1984; 36: 91-102
• 7 Vane JR. The use of isolated organs for detecting active substances in the circulating blood. Br J Pharmacol 1964; 23: 360-373
• 8 Furchgott RF, Bhadrakom S. Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs. J Pharmacol Exp Ther 1953; 108: 129-143
• 9 Hof RP, Vuorela HJ, Neumann P. PY 108-068, a new potent, and selective inhibitor of calcium-induced contraction of rabbit aortic rings. J Cardiovasc Pharmacol 1982; 4: 344-351
• 10 Bundy GL. The synthesis of prostaglandin endoperoxide analogs. Tetrahedron Lett 1975; 24: 1957-1960
• 11 Welch BL. The generalisation of “Students” problem when several different population variances are involved. Biometrika 1947; 34: 28-34
• 12 Joris I, Braunstein PW. Platelets and endothelium: effect of collagen- induced platelet aggregates on pulmonary vessels. Exp Molec Pathol 1982; 37: 393-405
• 13 Mallarkey G, Smith GM. A comparison of the efficacy of indometha- cin, dazoxiben and EP045 oh intravascular platelet aggregation in guinea-pigs and rats. Br J Pharmacol 1983; 79: 360 P
• 14 Smith GM, Duncan GG. A study of intravascular platelet aggregation by continuous platelet counting. Thromb Res 1981; 23: 275-288
• 15 Okamatsu S, Peck RC, Lefer AM. Effects of calcium channel blockers on arachidonate-induced sudden death in rabbits. Proc Soc Exp Biol Med 1981; 166: 551-555
• 16 Cerskus AL, Ali M, McDonald JW D. Thromboxane B₂and 6-keto- prostaglandin F_1αsynthesis during infusion of collagen and arachidonic acid in rabbits: inhibition by aspirin and sulphinpyrazone. Thromb Res 1980; 18: 693-705
• 17 Shimamoto T, Kobayashi M, Takahashi T, Motomiya T, Numano F, Morooka S. Heart attack induced experimentally with thromboxane A₂ . Proc Jap Acad. 1977; 53 (B) 38-42
• 18 Ellis EF, Oelz O, Roberts LJ, Payne NA, Sweetman BJ, Nies AS, Oates JA. Coronary arterial smooth muscle contraction by a substance released from platelets: evidence that it is thromboxane A2. Science 1976; 193: 1135-1137
• 19 Needleman P, Minkes M, Raz A. Thromboxanes: selective biosynthesis and distant biological properties. Science 1976; 193: 163-165
• 20 Lefer AM, Okamatsu S, Smith EF, Smith JB. Beneficial effects of a new thromboxane synthetase inhibitor in arachidonate-induced sudden death. Thromb Res 1981; 23: 265-273
• 21 Burke SE, Roth DM, Lefer AM. Antagonism of platelet aggregation by 13-aza-prostanoic acid in acute myocardial ischemia and sudden death. Thromb Res 1983; 29: 473-488
• 22 Jones RL, Wilson NH, Armstrong RA, Peesapati V, Smith GM. Effects of thromboxane antagonist EP045 on platelet aggregation. In Advances in prostaglandin, thromboxane and leukotriene research, 11. Samuelsson B, Paoletti R, Ramwell P. (Eds) pp 345-350 Raven Press; New York: 1983
• 23 Henry PD. Comparative pharmacology of calcium antagonists: nifedipine, verapamil and diltiazem. Am J Cardiol 1980; 46: 1047-1058
• 24 Ikeda Y, Kikuchi M, Toyama K, Watanabe K, Ando Y. Inhibition of human platelet functions by verapamil. Thromb Haemostas 1981; 45: 158-161
• 25 Johnsson H. Effects by nifedipine (Adalat) on platelet function in vitro and in vivo. Thromb Res 1981; 21: 523-528
• 26 Davi G, Novo S, Fiore M, Fodera A, Mattina A, Mazzola A, Strano A. Effects by nifedipine on thromboxane synthesis in vitro and in vivo. Thromb Res 1982; 28: 837-842
• 27 Han P, Boatwright C, Ardlie NG. Inhibition of platelet function by antiarrhythmic drugs verapamil and disopyramide. Thromb Haemostas 1982; 47: 150-153
• 28 Kristensen SD, Schmidt EB, Dyerberg J. Verapamil does not alter platelet function in patients with recent myocardial infarction. Thromb Res 1983; 32: 437-442